Information:
Error:
ID
45899
Description
Principal Investigator: Donald Bowden, PhD, Center for Human Genomics, Center for Diabetes Research, Wake Forest University School of Medicine, Winston-Salem, NC, USA MeSH: Diabetes Mellitus, Type 2 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001167 *The T2D Seq GWAS AA Cohort is utilized in the following dbGaP sub-studies.* To view genotypes, other molecular data, and derived variables collected in these sub-studies, please click on the following sub-studies below or in the "Sub-studies" box located on the right hand side of this top-level study page phs001167 T2D Seq GWAS AA Cohort.- phs000140 CIDR T2D Bowdens - phs001102 T2D GENES AA
Link
Keywords
Versions (1)
- 12/12/23 12/12/23 - Simon Heim
Copyright Holder
Donald Bowden, PhD, Center for Human Genomics, Center for Diabetes Research, Wake Forest University School of Medicine, Winston-Salem, NC, USA
Uploaded on
December 12, 2023
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
dbGaP phs001167 Type 2 Diabetes in African Americans, GWAS and Exome Sequencing
Sample ID, analyte type, body site, and tumor status of participants with or without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
- StudyEvent: SEV1
- Subject ID, race, age, gender, BMI, consent form(s) signed by participants, age of type 2 diabetes Mellitus diagnosis, age of end stage renal disease diagnosis, age of hypertension diagnosis, duration of type 2 diabetes Mellitus since diagnosis, individual has reported that he/she is on dialysis, individual has reported hypertension, individual has diabetic retinopathy reported by ophthalmologist or laser treatment with photocoagulation, HBA1C, pc1, pc2, pc3, pc4, pc5, pc6, pc7, pc8, pc9, and pc10 of participants with T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
- Subject ID, race, age, gender, BMI, fasting blood sugar, consent form(s) signed by participant, participant is fasting when he has not had anything to eat or drink 12 hours prior to blood draw, pc1, pc2, pc3, pc4, pc5, pc6, pc7, pc8, pc9, and pc10 of participants without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
- Subject ID, family ID, mother ID, father ID, gender, and monozygotic tween ID of participants with of without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
- Subject ID, consent group, subject source, source subject ID, and affection status of participants with or without T2D and involved in the "Type 2 Diabetes in African Americans, GWAS and Exome Sequencing" project.
- Subject ID, sample ID, sample source, source sample ID, sample use, if sample was used in analysis, and reason why sample was used in analysis of participants with or without T2D and involved in the "Type 2 Diabetes in African Americans, GWAS and Exome Sequencing" project.
- Subject ID, gender, age, T2D, diabetes age of diagnosis at time of study, height, weight, BMI, consortium name, and cohort name of participants with or without T2D and involved in the "Type 2 Diabetes Genetic Exploration by Next-generation Sequencing in Multi-Ethnic Samples (T2D-GENES) Project 1: Wake Forest African American Type 2 Diabetes" project.
- Sample ID, body site where sample was obtained, analyte type, histological type of sample, sequencing center, and tumor status of participants with or without T2D and involved in the "Type 2 Diabetes Genetic Exploration by Next-generation Sequencing in Multi-Ethnic Samples (T2D-GENES) Project 1: Wake Forest African American Type 2 Diabetes" project.
- Sample ID, analyte type, body site, and tumor status of participants with or without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
Similar models
Sample ID, analyte type, body site, and tumor status of participants with or without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
- StudyEvent: SEV1
- Subject ID, race, age, gender, BMI, consent form(s) signed by participants, age of type 2 diabetes Mellitus diagnosis, age of end stage renal disease diagnosis, age of hypertension diagnosis, duration of type 2 diabetes Mellitus since diagnosis, individual has reported that he/she is on dialysis, individual has reported hypertension, individual has diabetic retinopathy reported by ophthalmologist or laser treatment with photocoagulation, HBA1C, pc1, pc2, pc3, pc4, pc5, pc6, pc7, pc8, pc9, and pc10 of participants with T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
- Subject ID, race, age, gender, BMI, fasting blood sugar, consent form(s) signed by participant, participant is fasting when he has not had anything to eat or drink 12 hours prior to blood draw, pc1, pc2, pc3, pc4, pc5, pc6, pc7, pc8, pc9, and pc10 of participants without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
- Subject ID, family ID, mother ID, father ID, gender, and monozygotic tween ID of participants with of without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
- Subject ID, consent group, subject source, source subject ID, and affection status of participants with or without T2D and involved in the "Type 2 Diabetes in African Americans, GWAS and Exome Sequencing" project.
- Subject ID, sample ID, sample source, source sample ID, sample use, if sample was used in analysis, and reason why sample was used in analysis of participants with or without T2D and involved in the "Type 2 Diabetes in African Americans, GWAS and Exome Sequencing" project.
- Subject ID, gender, age, T2D, diabetes age of diagnosis at time of study, height, weight, BMI, consortium name, and cohort name of participants with or without T2D and involved in the "Type 2 Diabetes Genetic Exploration by Next-generation Sequencing in Multi-Ethnic Samples (T2D-GENES) Project 1: Wake Forest African American Type 2 Diabetes" project.
- Sample ID, body site where sample was obtained, analyte type, histological type of sample, sequencing center, and tumor status of participants with or without T2D and involved in the "Type 2 Diabetes Genetic Exploration by Next-generation Sequencing in Multi-Ethnic Samples (T2D-GENES) Project 1: Wake Forest African American Type 2 Diabetes" project.
- Sample ID, analyte type, body site, and tumor status of participants with or without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
SAMPID
Item
De-identified sample ID
string
C4684638 (UMLS CUI [1,1])
C1299222 (UMLS CUI [1,2])
C1299222 (UMLS CUI [1,2])
BODY_SITE
Item
Body site where sample was collected
string
C0449705 (UMLS CUI [1,1])
ANALYTE_TYPE
Item
Analyte type
string
C4744818 (UMLS CUI [1,1])
CL Item
Is not a tumor (N)
C0027651 (UMLS CUI [1,1])
C1518422 (UMLS CUI [1,2])
C1518422 (UMLS CUI [1,2])
CL Item
Is tumor (Y)
C0027651 (UMLS CUI [1,1])